Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) – Update Report


March 20, 2025
 / 
We have provided an update for Acurx following the release of the FY24 results and business update on 18 March 2025.

Professional research access

Full professional research is available to approved wholesale and professional clients. Access is subject to IIR approval and prequalification.

Already approved but unable to open this page? Contact Client Services.